Wavemaker Three-Sixty Health

Wavemaker Three-Sixty Health is a prominent U.S. venture capital firm specializing in early-stage investments within the healthcare sector. Established in 2018, the firm concentrates on seed-stage funding for healthcare disruptors aiming to revolutionize the industry. Their portfolio encompasses a diverse range of companies across North America, with a notable presence in the United States, Canada, and Singapore.

The firm's investment strategy is centered on sectors such as health-tech, digital health, medical devices, telehealth, artificial intelligence, pharma-tech, science, and marketplaces. By focusing on these areas, Wavemaker Three-Sixty Health seeks to support innovative solutions that address critical challenges in the healthcare industry. Their approach is distinguished by a commitment to backing entrepreneurs who are driving substantial transformation rather than incremental improvements.

With assets under management exceeding $85 million across two funds, Wavemaker Three-Sixty Health has invested in over 45 healthcare companies in less than four years. This rapid growth underscores their dedication to fostering innovation and their capacity to identify and support promising startups poised to make a significant impact in the healthcare sector.